Surgery Partners, Inc. cash flow statement SGRY

In fiscal 2025, which ended Dec 31, 2025, Surgery Partners, Inc. generated $274.3 million of cash from operations, down 8.6% from the year before. It spent $78.7 million on capital expenditures. That left free cash flow of $195.6 million.

USD in millions, except per-share amounts and ratios. The percent under a figure is the change from the year before.

Line
FY 2026
Jun 30, 2026
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
FY 2019
Dec 31, 2019
FY 2018
Dec 31, 2018
FY 2016
Dec 31, 2016
FY 2015
Dec 31, 2015
Operating
Depreciation and amortization
177
+10.3%
176
+15.3%
153
+29.2%
118
+2.9%
115
+16.2%
99
+4.2%
95
+23.9%
76
+13.5%
67
40
+14.5%
35
Stock-based compensation
10
-63.9%
15
-55.6%
33
+88.1%
18
-3.8%
18
+5.7%
17
+31.8%
13
+29.4%
10
+9.7%
9
2
-73.1%
8
Operating cash flow
258
-2.2%
274
-8.6%
300
+2.1%
294
+85.0%
159
+82.3%
87
-64.7%
247
+90.7%
130
-10.4%
145
125
+48.2%
84
Investing
Capital expenditures
70
-20.5%
79
-12.9%
90
+1.8%
89
+10.2%
81
+39.9%
58
+34.3%
43
-41.7%
74
+84.9%
40
39
+17.0%
33
Investing cash flow
-206
+12.8%
-247
+49.5%
-488
-116.5%
-226
+26.7%
-308
+7.2%
-332
-275.2%
-88
-3.8%
-85
+33.9%
-129
-185
-37.0%
-135
Financing
Debt issued
1,170
+43.3%
1,203
-30.5%
1,730
+109.3%
827
+279.5%
218
-27.3%
299
-30.3%
429
-15.3%
507
+79.3%
283
651
+231.4%
196
Debt repaid
1,051
+73.7%
1,040
-18.7%
1,279
+58.5%
807
-6.4%
862
+151.2%
343
+58.7%
216
-55.9%
491
+211.4%
158
473
+44.2%
328
Stock buybacks
—
—
—
—
—
—
0
0
-100.0%
2
0
0
Financing cash flow
-86
-1134.9%
-57
-121.9%
262
+268.8%
-155
-468.6%
42
-86.7%
316
+374.2%
67
+149.1%
-136
-2057.1%
-6
71
+113.6%
33
Change in cash
Net change in cash
-33
-191.3%
-30
-140.2%
74
+184.6%
-87
+18.7%
-107
-249.2%
72
-68.2%
225
+345.9%
-92
-1074.5%
9
—
—
Free cash flow
188
+7.0%
196
-6.7%
210
+2.3%
205
+162.1%
78
+165.1%
30
-85.5%
204
+264.9%
56
-46.7%
105
86
+68.7%
51
Per share
Free cash flow per share
1.46
+5.7%
1.54
-7.5%
1.66
+1.9%
1.63
+91.9%
0.85
+108.8%
0.41
—
—
2.18
1.79
+31.2%
1.36
Shareholder returns
Returned to shareholders
—
—
—
—
—
—
0
0
2
0
0
Share of free cash flow
—
—
—
—
—
—
0.00%
0.00%
1.91%
0.00%
0.00%
Ratios
Free cash flow margin
5.57%
5.91%
6.73%
7.47%
3.08%
1.33%
10.97%
3.05%
5.92%
7.52%
5.32%
Capital expenditures to revenue
2.09%
2.38%
2.90%
3.24%
3.17%
2.59%
2.31%
4.02%
2.25%
3.41%
3.48%
Stock-based compensation to revenue
0.30%
0.45%
1.07%
0.65%
0.72%
0.78%
0.71%
0.56%
0.52%
0.18%
0.78%
Cash conversion
—
—
—
—
—
—
—
—
—
13.25x
59.12x
How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and ratios. Capital expenditures, debt repaid, dividends, and buybacks are positive amounts. Investing and financing cash flow keep the filing sign, so an outflow is negative. Free cash flow is operating cash flow minus capital expenditures. The first column is the trailing twelve months through the latest quarter. Returned to shareholders is dividends plus buybacks. Free cash flow margin, capital expenditures, and stock-based compensation are divided by revenue. Cash conversion is operating cash flow divided by net income. More on our methodology.

Company profile

Industry
Services-General Medical & Surgical Hospitals, NEC (SIC 8062)
Listed as
SGRY (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Brentwood, TN
SEC filer status
Large accelerated filer
SEC CIK
1638833

Other Services-General Medical & Surgical Hospitals, NEC companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.